NEW YORK, May 16 - Lynx Therapeutics will provide gene expression services for the International Livestock Research Institute in
Lynx will use its Massively Parallel Signature Sequencing (MPSS) technology to analyze gene expression in livestock parasites and their vectors. Initially, it will study Theileria parva, a parasite that causes east coast fever in cattle. It will also analyze gene expression in different tissues from tsetse flies.
The company said it will receive payments for these services.